Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!

  • Filter By:
  • Above and Beyond Glycemic Control
  • CMEVIDEO

  • Above and Beyond Glycemic Control

  • March 21, 2013
  • Patients with type 2 diabetes still remain at high risk for cardiovascular events despite current standards of care. Intensive glucose reduction alone has not been able to lower the risk of major… More »
  • Credit Type(s): CME | Credit: 1.5
  • CME

  • Cardiovascular Consults: Volume 2, Number 1

  • October 1, 2012
  • While metformin remains the mainstay of first-line pharmacotherapy for type 2 diabetes, clinical evidence does not yet support a clear line of succession for treatment subsequent to metformin… More »
  • Credit Type(s): CME | Credit: 1.25
  • CME

  • Practical Lipidology: Volume 2, Number 2

  • September 1, 2012
  • Elevated plasma triglycerides are linked to insulin resistance, and both disorders are associated with increased cardiovascular risk. Experts often debate which condition comes first, but evidence… More »
  • Credit Type(s): CME | Credit: 1.5
  • CME

  • Practical Lipidology: Volume 2, Number 1

  • July 1, 2012
  • For most patients with dyslipidemia, the primary goal of therapy is reduction of low-density lipoprotein cholesterol (LDL-C) levels to a clinically acceptable target. However, achieving this target… More »
  • Credit Type(s): CME | Credit: 1.5